Skin-to-skin After Delivery in Preterm Infants Born at 28-32 Weeks of Gestation

Sponsor
Norwegian University of Science and Technology (Other)
Overall Status
Recruiting
CT.gov ID
NCT02024854
Collaborator
St. Olavs Hospital (Other), Drammen sykehus (Other), Sorlandet Hospital HF (Other), IWK Health Centre (Other)
136
4
2
106
34
0.3

Study Details

Study Description

Brief Summary

The aim of the study is to investigate physiological response, social/emotional response and general movements in preterm infants when they are given skin-to-skin contact with the mother (intervention) or standard care (incubator) right after delivery. Preterm infants will be randomized to either intervention or standard care group. Data on body temperature, blood glucose, hart rate, respiration rate and oxygen saturation will be obtained. In addition the infant will be video-recorded during the first 24 hours and at three months of age for analysis of the general movements.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: skin-to-skin
  • Behavioral: standard care
N/A

Detailed Description

Power calculations are based on a difference in Bayley Scale of Infant Development III, cognitive scale at two years corrected age of about 7,5 mean score =0.5 SD (α=0,05, β=0.80). Based on this analysis, 64 preterm infants are needed in each group to yield statistic significance. Allowing for withdrawals, the sample size is set to 68 in each group.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
136 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Skin-to-skin After Delivery in Preterm Infants Born at 28-32 Weeks of Gestation. A Randomized Controlled Trial
Actual Study Start Date :
Feb 1, 2014
Anticipated Primary Completion Date :
Dec 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: skin-to-skin

immediately after birth the baby is laid on mother's chest for as long as justifiable medically to max 2 hours.

Behavioral: skin-to-skin

Active Comparator: standard care

after birth the baby is transferred to the neonatal intensive care unit

Behavioral: standard care

Outcome Measures

Primary Outcome Measures

  1. cognitive scorer at two years corrected age [2 year]

    measured by Bayley Scales of Infant Development Third Edition (BSID III)

Secondary Outcome Measures

  1. change in heart rate [24 hours]

  2. change in body temperature [24 hours]

  3. change in respiration frequency [24 hours]

  4. change in blood glucose [24 hours]

  5. general movements (GM) at 3 months corrected age [3 months]

    assessed with the General Movement Assessment (GMA)

  6. Nutrition [1 year]

    based on a Norwegian questionnaire, based on a Norwegian national survey from The Norwegian Directorate of Health.

  7. Social/emotional competence at three months corrected age [3 months]

    measured with the Ages and Stages Questionnaire: Social Emotional (ASQ:SE)

  8. Social/emotional competence at two years corrected age [1 year]

    measured with the Ages and Stages Questionnaire: Social Emotional (ASQ:SE)

  9. Social/emotional competence at two years corrected age [2 years]

    measured with the Ages and Stages Questionnaire: Social Emotional (ASQ:SE)

  10. Developmental skills at two years corrected age [1 year]

    measured with the Ages and Stages Questionnaire: (ASQ)

  11. Developmental skills at two years corrected age [2 years]

    measured with the Ages and Stages Questionnaire: (ASQ)

  12. Maternal anxiety [at discharge from hospital]

    measured with State-Trait Anxiety Inventory (STAI)

  13. Maternal anxiety [3 months]

    measured with State-Trait Anxiety Inventory (STAI)

  14. Maternal anxiety [2 years]

    measured with State-Trait Anxiety Inventory (STAI)

Eligibility Criteria

Criteria

Ages Eligible for Study:
28 Weeks to 32 Weeks
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Preterm infants at 28-32 weeks of gestation (born 12-8 weeks before term)
Exclusion Criteria:
  • Infants who need immediate medical interventions

Contacts and Locations

Locations

Site City State Country Postal Code
1 IWK Health Centre Halifax Canada
2 Nyfødt intensiv, Drammen sykehus Drammen Norway
3 Nyfødt intensiv, Sørlandet Sykehus Kristiansand Norway
4 NICU St Olavs Hospital Trondheim Norway

Sponsors and Collaborators

  • Norwegian University of Science and Technology
  • St. Olavs Hospital
  • Drammen sykehus
  • Sorlandet Hospital HF
  • IWK Health Centre

Investigators

  • Study Director: Håkon Bergseng, md phd, Norwegian University of Science and Technology

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
NCT02024854
Other Study ID Numbers:
  • KC28-32
First Posted:
Dec 31, 2013
Last Update Posted:
Mar 15, 2022
Last Verified:
Mar 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Norwegian University of Science and Technology
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 15, 2022